Trump is reportedly trying to lure a German company working on coronavirus vaccine exclusively to the U.S.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
No one can fault President Trump for wanting Americans to have access to a coronavirus vaccine in the future, but Germany isn't pleased with the way he's reportedly trying to do it.
Per Reuters, Germany's health ministry confirmed a report from German Newspaper Welt am Sonntag that said Trump has offered funds to lure biopharmaceutical company CureVac, which is working on developing a vaccine for the new virus, from Germany to the United States. Welt am Sonntag quoted an anonymous German official who said Trump would do anything to get a vaccine, "but only for the United States."
A German health ministry official, meanwhile, said Berlin wants to make sure vaccines and other substances that could be used to fight off the coronavirus are developed in Germany and Europe, as well. Above all, the hope is to avoid exclusivity.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The exclusive sale of a possible vaccine to the USA must be prevented by all means," tweeted Karl Lauterbach, a professor of health economics epidemiology and German lawmaker, in response to the report. "Capitalism has limits."
There was no immediate comment from the U.S. embassy in Berlin, and CureVac declined to comment, but the company's CEO Daniel Menichella met with Trump, Vice Presidnet Mike Pence, and other members of the White House Coronavirus Task Force earlier this month.
CureVac is narrowing its field of vaccine candidates, and hopes to begin testing in June or July. Read more at Reuters.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Buddhist monks’ US walk for peaceUnder the Radar Crowds have turned out on the roads from California to Washington and ‘millions are finding hope in their journey’
-
American universities are losing ground to their foreign counterpartsThe Explainer While Harvard is still near the top, other colleges have slipped
-
How to navigate dating apps to find ‘the one’The Week Recommends Put an end to endless swiping and make real romantic connections
-
TikTok: New owners, same risksFeature What are Larry Ellison’s plans for TikTok US?
-
Trump wants a weaker dollar, but economists aren’t so sureTalking Points A weaker dollar can make imports more expensive but also boost gold
-
Leadership: A conspicuous silence from CEOsFeature CEOs were more vocal during Trump’s first term
-
The end for central bank independence?The Explainer Trump’s war on the US Federal Reserve comes at a moment of global weakening in central bank authority
-
Can Trump make single-family homes affordable by banning big investors?Talking Points Wall Street takes the blame
-
TikTok secures deal to remain in USSpeed Read ByteDance will form a US version of the popular video-sharing platform
-
Unemployment rate ticks up amid fall job lossesSpeed Read Data released by the Commerce Department indicates ‘one of the weakest American labor markets in years’
-
Phish food for thought: Ben & Jerry’s political turmoilIn the Spotlight War of words over brand activism threatens to ‘overshadow’ the big ice cream deal
